Colorectal cancer. New Zealand s place in the world. Inequities in outcomes? Assoc Prof Diana Sarfati

Size: px
Start display at page:

Download "Colorectal cancer. New Zealand s place in the world. Inequities in outcomes? Assoc Prof Diana Sarfati"

Transcription

1 Colorectal cancer New Zealand s place in the world. Inequities in outcomes? Assoc Prof Diana Sarfati

2 Today s talk Mortality Internationally In New Zealand Incidence Trends in New Zealand Primary prevention Survival Internationally Unequal outcomes? Screening pilot

3 Source: OECD Health Data NZ has high death rates from colorectal cancer Age-standardised rates per population

4 Source: OECD Health Data NZ has high death rates from colorectal cancer Age-standardised rates per population

5 In New Zealand Around 3000 CRC every year of which about a third are rectal cancers in New Zealand Colorectal cancer is the second highest cause of cancer death in New Zealand

6 Today s talk Mortality Internationally In New Zealand Incidence Trends in New Zealand Primary prevention Survival Internationally Unequal outcomes? Screening pilot

7 Incidence rates of CRC are coming down Males Females Ministry of Health Cancer Projections: Incidence to Wellington: Ministry of Health.

8 Number of cases of CRC are going up Ministry of Health Cancer: New registrations and deaths Wellington: Ministry of Health.ealth.

9 Colorectal cancer: incidence is lower for Maori... But increasing Point number hdgdhu skjojsd asdsd Sdfsd sdfsds lkl; Sdasd gh fgdfg dfg d dfgg Maori Pacific European/ Other Asian Blakely et al. CancerTrends: Trends in Incidence by Ethnic and Socioeconomic Group, New Zealand

10 Primary prevention of CRC Strong cohort effects Early life exposures? Dietary factors Physical inactivity Overweight/ obesity Smoking Alcohol Daily aspirin

11 Today s talk Mortality Internationally In New Zealand Incidence Trends in New Zealand Primary prevention Survival Internationally Unequal outcomes? Screening pilot

12 International comparison: Five-year relative survival in OECD countries Japan Iceland Belgium United States Korea Canada Norway Austria New Zealand Finland Netherlands Malta Sweden Germany OECD (16) Singapore Portugal France Slovenia Denmark United Kingdom Ireland Czech Republic Latvia

13 Survival rates are improving over time Excess mortality rate has been reducing by 27% each 10 years since early 1990 s for those diagnosed with colorectal cancer Soeberg M, Blakely T, Sarfati D et al (2012). Cancer Trends: Trends in Survival by Ethnic and Socioeconomic Group, New Zealand Wellington: University of Otago and Ministry of Health.

14 Not all good news (inequities)

15 Why ethnic inequities in cancer survival? More aggressive/ advanced tumours? Patient comorbidity? Health care quality and/or access?

16 Ethnic inequities in colon cancer survival 40% Excess mortality risk (Maori/non-Maori) 30% 20% 10% Comorbidity and treatment/health service factors each accounted for a third of the survival difference. 0% Unadjusted Demographics + Disease factors + Patient factors Risk adjustments + Treatment + Health service access Hill S, Sarfati D et al. Cancer. 2010: 116;

17 Ethnic inequities in colon cancer survival Percentage of cohort (stage III) Referred to oncologist Reviewed by oncologist Offered adjuvant chemo Received adjuvant chemo Started within 8 weeks 10 0 Māori non-māori Hill S, Sarfati D, et al J Epidemiol Comm Health 2010: 64;

18 Not just colon cancer Māori were four times less likely to receive curative rather than palliative anticancer treatment for nonmetastatic disease compared with Europeans even after adjusting for age, gender, NZDep, CCI [comorbidity], tumor type, stage and patient declining management. Stevens W, Stevens G et al. Ethnic differences in the management of lung cancer in NZ. J Thoracic Oncol 2008.

19 Bowel cancer mortality: What s happening over time? Shaw C, Blakely T, Sarfati D, et al. Trends in colorectal cancer mortality by ethnicity and socioeconomic position in New Zealand : One country, many stories. Aust NZ J Public Health. 2006; 30 (1): Point number hdgdhu skjojsd asdsd Sdfsd sdfsds lkl; Sdasd gh fgdfg dfg d dfgg

20 Today s talk Mortality Internationally In New Zealand Incidence Trends in New Zealand Primary prevention Survival Internationally Unequal outcomes? Screening pilot

21 Screening Waitemata DHB 2 yearly ifobt for those aged years.

22 How is the pilot programme going? Participation: Participation rate 70% 60% 50% 40% 30% 20% 10% Desirable rate 0% Maori Pacific Asian Other Ministry of Health 2013

23 How is the pilot programme going? Around 130 cancers detected to Sept last year High detection of advanced adenomas Very high acceptance of colonoscopy

24 How is the pilot programme going? Screened diagnoses Colon Cancer study TNM Stage at diagnosis

25 Where to from here for bowel cancer? Primary prevention Screening programme Minimum treatment standards Data availability

The uneven playing field: Inequi3es in cancer care and outcomes in New Zealand

The uneven playing field: Inequi3es in cancer care and outcomes in New Zealand The uneven playing field: Inequi3es in cancer care and outcomes in New Zealand Māori: Indigenous New Zealanders British colonisation Māori now 15% NZ pop Health inequalities All cancers, incidence and

More information

508 the number of suicide deaths in deaths per 100,000 people was the suicide rate in Suicide deaths in 2013 by gender

508 the number of suicide deaths in deaths per 100,000 people was the suicide rate in Suicide deaths in 2013 by gender An overview of suicide statistics This document summarises information about suicide deaths in New Zealand covering up to 13. It does not attempt to explain causes of suicidal behaviour or causes of changes

More information

Blakely T, Tobias M et al. Tracking disparity: Trends in ethnic and socioeconomic inequalities in mortality, Wellington: Ministry of

Blakely T, Tobias M et al. Tracking disparity: Trends in ethnic and socioeconomic inequalities in mortality, Wellington: Ministry of Ethnic disparities in colon cancer survival in New Zealand Dr Diana Sarfati University of Otago Wellington Māori Cancer Conference; Aug 2009 Acknowledgements Sarah Hill Project team Bridget Robson, Donna

More information

Cancer, Care and Comorbidity. Associate Professor Diana Sarfati

Cancer, Care and Comorbidity. Associate Professor Diana Sarfati Cancer, Care and Comorbidity Associate Professor Diana Sarfati Why do we care? Comorbidity: is common among cancer patients. has a major impact on patients. has a major impact on health services. Is an

More information

Trends and disparities in cancer in Aotearoa/ NZ

Trends and disparities in cancer in Aotearoa/ NZ Trends and disparities in cancer in Aotearoa/ NZ Professor Diana Sarfati #cancercrossroads @DiSarfati Why cancer? Estimated number of incident cases from 2018 to 2040 in New Zealand, all cancers, both

More information

C3: Cancer, Care and Comorbidity

C3: Cancer, Care and Comorbidity C3: Cancer, Care and Comorbidity Symposium April 2014 Comorbidity: Why do we care? is common among cancer patients. has a major impact on patients. has a major impact on health services. Is an important

More information

MENTAL HEALTH CARE. OECD HCQI Expert meeting 17 th of May, Rie Fujisawa

MENTAL HEALTH CARE. OECD HCQI Expert meeting 17 th of May, Rie Fujisawa MENTAL HEALTH CARE OECD HCQI Expert meeting 17 th of May, 2013 Rie Fujisawa Mental health indicators Any hospital readmissions for patients with schizophrenia Same hospital readmissions for patients with

More information

Prof Stephen P. Halloran. Update on the NHS Bowel Cancer Screening Programme Focus on BS & FIT

Prof Stephen P. Halloran. Update on the NHS Bowel Cancer Screening Programme Focus on BS & FIT Prof Stephen P. Halloran Update on the NHS Bowel Cancer Screening Programme Focus on BS & FIT World Top 20 Cancers Men Incidence & Mortality (2012) Women World Colorectal Cancer 3 rd commonest cancer 4

More information

Implementing of Population-based FOBT Screening

Implementing of Population-based FOBT Screening Implementing of Population-based FOBT Screening gfobt to FIT Experience from England Prof Stephen P. Halloran Guaiac FOBt Haem 2H 2 O 2 = 2H 2 0 + O 2 Oxidised guaiaconic acid is blue Biennial Bowel Cancer

More information

The health economic landscape of cancer in Europe

The health economic landscape of cancer in Europe 1 Approval number The health economic landscape of cancer in Europe Bengt Jönsson, Professor Emeritus of Health Economics Stockholm School of Economics 2 Disclaimer This presentation was developed by Professor

More information

WCPT COUNTRY PROFILE December 2017 SWEDEN

WCPT COUNTRY PROFILE December 2017 SWEDEN WCPT COUNTRY PROFILE December 2017 SWEDEN SWEDEN NUMBERS WCPT Members Practising physical therapists 11,043 Total number of physical therapist members in your member organisation 17,906 Total number of

More information

WCPT COUNTRY PROFILE December 2017 HUNGARY

WCPT COUNTRY PROFILE December 2017 HUNGARY WCPT COUNTRY PROFILE December 2017 HUNGARY HUNGARY NUMBERS WCPT Members Practising physical therapists 727 Total number of physical therapist members in your member organisation 4,000 Total number of practising

More information

WCPT COUNTRY PROFILE December 2017 SERBIA

WCPT COUNTRY PROFILE December 2017 SERBIA WCPT COUNTRY PROFILE December 2017 SERBIA SERBIA NUMBERS WCPT Members Practising physical therapists 622 Total number of physical therapist members in your member organisation 3,323 Total number of practising

More information

Caring for cancer patients with comorbidity. Chair: Associate Professor Diana Sarfa3

Caring for cancer patients with comorbidity. Chair: Associate Professor Diana Sarfa3 Caring for cancer patients with comorbidity Chair: Associate Professor Diana Sarfa3 Why do we care? Comorbidity: is common among cancer pa3ents. has a major impact on pa3ents. has a major impact on health

More information

Table 6.1 Summary information for colorectal cancer in Ireland,

Table 6.1 Summary information for colorectal cancer in Ireland, 6 Colorectal cancer 6.1 Summary Colorectal cancer is the second most common cancer in Ireland (excluding non-melanoma skin cancer). It accounts for 12% of all malignant neoplasia in females and 15% in

More information

The cancer burden in the European Union and the European Region: the current situation and a way forward

The cancer burden in the European Union and the European Region: the current situation and a way forward The cancer burden in the European Union and the European Region: the current situation and a way forward Presented by Zsuzsanna Jakab WHO Regional Director for Europe Informal Meeting of Health Ministers

More information

LEBANON. WCPT COUNTRY PROFILE December 2018

LEBANON. WCPT COUNTRY PROFILE December 2018 LEBANON WCPT COUNTRY PROFILE December 2018 LEBANON NUMBERS 1600 1400 1200 1000 800 600 400 200 0 Physical therapists in the country Members in MO 1,480 1,480 Total PTs in country 800000 700000 600000 500000

More information

DENMARK. WCPT COUNTRY PROFILE December 2018

DENMARK. WCPT COUNTRY PROFILE December 2018 DENMARK WCPT COUNTRY PROFILE December 2018 DENMARK NUMBERS 14000 12000 10000 8000 6000 4000 2000 0 Physical therapists in the country Members in MO 11,720 12,975 Total PTs in country 800000 700000 600000

More information

31 countries (117 registries, 20 national) Increased coverage in countries with regional registries 50% European population Overall >20 million

31 countries (117 registries, 20 national) Increased coverage in countries with regional registries 50% European population Overall >20 million 31 countries (117 registries, 20 national) Increased coverage in countries with regional registries 50% European population Overall >20 million cancer cases Adult patients (age 15+) 45 major cancer sites

More information

GERMANY. WCPT COUNTRY PROFILE December 2018

GERMANY. WCPT COUNTRY PROFILE December 2018 GERMANY WCPT COUNTRY PROFILE December 2018 GERMANY NUMBERS 160000 140000 120000 100000 80000 60000 40000 20000 0 Physical therapists in the country Members in MO 21,502 136,000 Total PTs in country 800000

More information

Ethnic inequalities in mortality: Trends and explanations,

Ethnic inequalities in mortality: Trends and explanations, Pharmac, Oct 2009 Professor Tony Blakely Ethnic inequalities in mortality: Trends and explanations, 1981-2004 Acknowledgments: Tobias, Atkinson, Woodward, and too many more to name 1 Index Structure of

More information

UK bowel cancer care outcomes: A comparison with Europe

UK bowel cancer care outcomes: A comparison with Europe UK bowel cancer care outcomes: A comparison with Europe What is bowel cancer? Bowel cancer, which is also known as colorectal or colon cancer, is a cancer that affects either the colon or the rectum. The

More information

Smokefree Policies in Europe: Are we there yet?

Smokefree Policies in Europe: Are we there yet? Smokefree Policies in Europe: Are we there yet? 14 April 2015, 9:00 10:30am Rue de l Industrie 24, 1040 Brussels Permanent Partners: Temporary Partners: The research for the SFP Smokefree Map was partially

More information

NATIONAL COST OF OBESITY SEMINAR. Dr. Bill Releford, D.P.M. Founder, Black Barbershop Health Outreach Program

NATIONAL COST OF OBESITY SEMINAR. Dr. Bill Releford, D.P.M. Founder, Black Barbershop Health Outreach Program NATIONAL COST OF OBESITY SEMINAR Dr. Bill Releford, D.P.M. Founder, Black Barbershop Health Outreach Program 1 INTRODUCTION According to the Center of Disease Control and Prevention, the American society

More information

Men & Health Work. Difference can make a difference Steve Boorman & Ian Banks RSPH Academy 2013

Men & Health Work. Difference can make a difference Steve Boorman & Ian Banks RSPH Academy 2013 Men & Health Promotion @ Work Difference can make a difference Steve Boorman & Ian Banks RSPH Academy 2013 Difference can make a Difference Mens health: State of mens health Use of services Role of the

More information

THE NEW ZEALAND MEDICAL JOURNAL

THE NEW ZEALAND MEDICAL JOURNAL THE NEW ZEALAND MEDICAL JOURNAL Journal of the New Zealand Medical Association Sociodemographic characteristics of New Zealand adult smokers, ex-smokers, and non-smokers: results from the 2006 Census Sharon

More information

PROGRESS ON HCQI RESEARCH AND DEVELOPMENT WORK

PROGRESS ON HCQI RESEARCH AND DEVELOPMENT WORK PROGRESS ON HCQI RESEARCH AND DEVELOPMENT WORK Ian Brownwood, HCQI Project, OECD HCQI Expert Group Meeting 21 and 22 may 2015 R&D Agenda for 2014 Primary Care Indicators Avoidable Hospital Admission Indicators

More information

Numbers and Narratives

Numbers and Narratives Unequal Impact: Numbers and Narratives Revolution of Cancer Care, National Māori Cancer Forum Rotorua, August 2009 Bridget Robson and Donna Cormack Te Rōpū RangahauHauoraa EruPōmare University of Otago

More information

Allied Health: Sustainable Integrated Health Care for all Australians

Allied Health: Sustainable Integrated Health Care for all Australians Allied Health: Sustainable Integrated Health Care for all Australians Catherine Turnbull Chief Allied and Scientific Health Advisor SA Health Presentation to Indigenous Allied Health Australia Conference,

More information

Overview of drug-induced deaths in Europe - What does the data tell us?

Overview of drug-induced deaths in Europe - What does the data tell us? Overview of drug-induced deaths in Europe - What does the data tell us? João Matias, Isabelle Giraudon, Julián Vicente EMCDDA expert group on the key-indicator Drug-related deaths and mortality among drug

More information

THE CVD CHALLENGE IN NORTHERN IRELAND. Together we can save lives and reduce NHS pressures

THE CVD CHALLENGE IN NORTHERN IRELAND. Together we can save lives and reduce NHS pressures THE CVD CHALLENGE IN NORTHERN IRELAND Together we can save lives and reduce NHS pressures The challenge of CVD continues today. Around 225,000 people in Northern Ireland live with the burden of cardiovascular

More information

IOSH No Time to Lose campaign: working together to tackle asbestos-related cancer #NTTLasbestos. Jonathan Hughes IOSH Vice President

IOSH No Time to Lose campaign: working together to tackle asbestos-related cancer #NTTLasbestos. Jonathan Hughes IOSH Vice President IOSH No Time to Lose campaign: working together to tackle asbestos-related cancer #NTTLasbestos Jonathan Hughes IOSH Vice President About the Institution of Occupational Safety and Health (IOSH) www.iosh.co.uk

More information

Pharmaceutical, Medical and Health-related Government and Regulatory bodies around the world.

Pharmaceutical, Medical and Health-related Government and Regulatory bodies around the world. 1 International International Conference on Harmonization (ICH) World Health Organization (WHO) 2 Argentina National Administration of Drugs, Food and medical Technology. Australia s Department of health

More information

European Partnership for Screening

European Partnership for Screening European Partnership for Screening Lawrence von Karsa Quality Assurance Group European Cancer Network for Screening and Prevention International Agency for Research on Cancer Lyon, France Work Package

More information

Cross Border Genetic Testing for Rare Diseases

Cross Border Genetic Testing for Rare Diseases Cross Border Genetic Testing for Rare Diseases EUCERD Joint Action WP8 Helena Kääriäinen National Institute for Health an Welfare, Helsinki, Finland Starting point Possibilities and demand for genetic

More information

CARDIOVASCULAR DISEASE AND DIABETES:

CARDIOVASCULAR DISEASE AND DIABETES: CARDIOVASCULAR DISEASE AND DIABETES: HOW OECD HEALTH SYSTEMS DELIVER BETTER OUTCOMES? Progress report 7 th November 2013 Outline Overview of the project Preliminary results Descriptive Analytical Next

More information

Manuel Cardoso RARHA Executive Coordinator Public Health MD Senior Advisor Deputy General-Director of SICAD - Portugal

Manuel Cardoso RARHA Executive Coordinator Public Health MD Senior Advisor Deputy General-Director of SICAD - Portugal Manuel Cardoso RARHA Executive Coordinator Public Health MD Senior Advisor Deputy General-Director of SICAD - Portugal Public Health Public health is the science and art of preventing disease, prolonging

More information

Differences make a Difference

Differences make a Difference Differences make a Difference The European Mens Health Forum: Overview European Mens Health: An oxymoron? Mens use of services: Self-care & navigation Good practice: Wot does work? A Storm is coming: Man

More information

What were the key findings from the routinely-collected data?

What were the key findings from the routinely-collected data? What were the key findings from the routinely-collected data? Dr Jason Gurney MoH National Health Board Cancer Registry (n=14,096) Hospitalisation and other Databases Mortality Database Notes Review (Upper

More information

Bowel Cancer Quality Improvement Report

Bowel Cancer Quality Improvement Report Bowel Cancer Quality Improvement Report 2019 Released 2019 health.govt.nz This report publishes quality performance indicator data from patients diagnosed with colorectal cancer in New Zealand between

More information

Screening for Cervical Cancer in Europe

Screening for Cervical Cancer in Europe Asturias, 23 October, 2011 Asturias, 23 October Screening for Cervical Cancer in Europe M. Arbyn Unit Cancer Epidemiology, IPH, Brussels, Belgium Rue Juliette Wytsmanstraat 14 1050 Brussels Belgium T +32

More information

Table 7.1 Summary information for lung cancer in Ireland,

Table 7.1 Summary information for lung cancer in Ireland, 7 Lung cancer 7.1 Summary Lung cancer is the third most common cancer in Ireland, accounting for 15% of cancers in men and 9% in women, if non-melanoma skin cancer is excluded (table 7.1). Each year, approximately

More information

Department of Biological Standardisation OMCL Network & Healthcare (DBO)

Department of Biological Standardisation OMCL Network & Healthcare (DBO) Department of Biological Standardisation OMCL Network & Healthcare (DBO) Implementation of Pathogen Reduction Technologies for Blood Components for Transfusion: Updated Table 2009-2010 COUNCIL OF EUROPE

More information

The OECD Health Care Quality Indicators Project

The OECD Health Care Quality Indicators Project The OECD Health Care Quality Indicators Project Ed Kelley, Ph.D. Head, OECD Health Care Quality Indicators Project Health Systems Working Party Luxembourg - April 26, 2005 1 Broad aims of the OECD s HCQI

More information

THE NEW ZEALAND MEDICAL JOURNAL

THE NEW ZEALAND MEDICAL JOURNAL THE NEW ZEALAND MEDICAL JOURNAL Journal of the New Zealand Medical Association Colonoscopy requirements of population screening for colorectal cancer in New Zealand Terri Green, Ann Richardson, Susan Parry

More information

Hazardous drinking in 2011/12: Findings from the New Zealand Health Survey

Hazardous drinking in 2011/12: Findings from the New Zealand Health Survey Hazardous drinking in 11/12: Findings from the New Zealand Health Survey This report presents key findings about alcohol use and hazardous drinking among adults aged 15 years and over, which come from

More information

Best practices in collecting and processing data in CRC screening and after it

Best practices in collecting and processing data in CRC screening and after it Best practices in collecting and processing data in CRC screening and after it The potential of harmonized information policy in effective national implementation of CRC screening Ladislav Dušek, Czech

More information

Inequalities in health: challenges and opportunities in Europe Dr Zsuzsanna Jakab WHO Regional Director for Europe

Inequalities in health: challenges and opportunities in Europe Dr Zsuzsanna Jakab WHO Regional Director for Europe Inequalities in health: challenges and opportunities in Europe Dr Zsuzsanna Jakab WHO Regional Director for Europe 21st Congress of the European Association of Dental Public Health 1 October 2016 Budapest

More information

Engagement in language assessment / Regions of Europe

Engagement in language assessment / Regions of Europe Summary table: Engagement in language / Regions of This table lists the statistically significant differences in the engagement in activities by the respondents from different s of : If the word or appears

More information

Atherosclerotic Cardiovascular Diseases: ischaemic heart disease and stroke

Atherosclerotic Cardiovascular Diseases: ischaemic heart disease and stroke «L Europe de la santé au service des patients» 13-14 October 2008 - Institut Pasteur Paris Atherosclerotic Cardiovascular Diseases: ischaemic heart disease and stroke Simona Giampaoli National Centre of

More information

An Update on the Bowel Cancer Screening Programme. Natasha Djedovic, London Hub Director 17 th September 2018

An Update on the Bowel Cancer Screening Programme. Natasha Djedovic, London Hub Director 17 th September 2018 An Update on the Bowel Cancer Screening Programme Natasha Djedovic, London Hub Director 17 th September 2018 NHS Bowel Cancer Screening Programme 2006: 60-69 yr old men & women offered guaiac Faecal Occult

More information

Cardiovascular Disease and Diabetes Policies for Better Health and Quality of Care

Cardiovascular Disease and Diabetes Policies for Better Health and Quality of Care Policy Brief Cardiovascular Disease and Diabetes Policies for Better Health and Quality of Care June 2015 Directorate for Employment, Labour and Social Affairs Over the last few decades, mortality from

More information

Yersiniosis SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods. Epidemiology

Yersiniosis SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods. Epidemiology SURVEILLANCE REPORT Annual Epidemiological Report for 2015 Yersiniosis Key facts In 2015, 26 countries reported 7 279 confirmed yersiniosis cases in the EU/EEA. The overall notification rate was 2.0 cases

More information

Where we stand in EFORT

Where we stand in EFORT Where we stand in EFORT Engaging with the new EU regulatory landscape for medical devices. Challenges & opportunities Brussel, Belgium April 6, 2018 Per Kjaersgaard-Andersen Associate Professor Section

More information

Indicators of suicide among people with serious mental illness

Indicators of suicide among people with serious mental illness Indicators of suicide among people with serious mental illness OECD/Denmark Mette Jørgensen, Søren Paaske Johnsen, Poul Erik Hansen, Katrine Grau, Jette Bauer and Jan Mainz Friday 14th November 2014 Agenda

More information

D7.1 Report summarising results of survey of EU countries to identify volumes and trends in relation to the import and export of stem cells

D7.1 Report summarising results of survey of EU countries to identify volumes and trends in relation to the import and export of stem cells Disclaimer: The content of this Deliverable represents the views of the author only and is his/her sole responsibility; it cannot be considered to reflect the views of the European Commission and/or the

More information

Main developments in past 24 hours

Main developments in past 24 hours ECDC DAILY UPDATE Pandemic (H1N1) 2009 Update 02 October 2009, 09:00 hours CEST Main developments in past 24 hours Weekly Influenza Surveillance Overview to be published today; Media highlights and Eurosurveillance

More information

Overall survival: 1 st line therapy

Overall survival: 1 st line therapy 1 3 Overall survival: 1 st line therapy 2-year OS phase III studies mm Prices per month of oncology medicin Bloomberg Business weekly 26 Feb 2015 Presented By Veena Shankaran at 2016 ASCO Annual Meeting

More information

D7.1 Report summarising results of survey of EU countries to identify volumes and trends in relation to the import and export of stem cells

D7.1 Report summarising results of survey of EU countries to identify volumes and trends in relation to the import and export of stem cells Disclaimer: The content of this Deliverable represents the views of the author only and is his/her sole responsibility; it cannot be considered to reflect the views of the European Commission and/or the

More information

Table 9.1 Summary information for stomach cancer in Ireland,

Table 9.1 Summary information for stomach cancer in Ireland, 9 Stomach cancer 9.1 Summary Stomach cancer ranks seventh in terms of the most common cancers in Ireland, accounting for 4.1% of all malignant neoplasia in men and 2.8% in women, when non-melanoma skin

More information

Extract from Cancer survival in Europe by country and age: results of EUROCARE-5 a population-based study

Extract from Cancer survival in Europe by country and age: results of EUROCARE-5 a population-based study EUROCARE-5 on-line database Data and methods Extract from Cancer survival in Europe 1999 2007 by country and age: results of EUROCARE-5 a population-based study De Angelis R, Sant M, Coleman MP, Francisci

More information

Alcohol Prevention Day

Alcohol Prevention Day Alcohol Prevention Day Rome, 16 May 2018 Hana Horka Policy Officer, Unit C4 Health Determinants and International Relations European Commission DG Health and Food Safety (SANTE) Alcohol consumption in

More information

FOURIER STUDY GREYLOCK PRESS: CTS PRODUCT SAMPLE - FOURIER YES. Did the study achieve its main objective?

FOURIER STUDY GREYLOCK PRESS: CTS PRODUCT SAMPLE - FOURIER YES. Did the study achieve its main objective? FOURIER STUDY Did the study achieve its main objective? 2 15% 1 5% 9.8% YES FOURIER compared Repatha with placebo in patients who were taking a statin and had hardening or narrowing of the arteries and

More information

European Collaboration on Dementia. Luxembourg, 13 December 2006

European Collaboration on Dementia. Luxembourg, 13 December 2006 European Collaboration on Dementia Luxembourg, 13 December 2006 2005 Call for projects Special attention has also to be given to information and definition of indicators on neurodegenerative, neurodevelopment,

More information

PARALLELISM AND THE LEGITIMACY GAP 1. Appendix A. Country Information

PARALLELISM AND THE LEGITIMACY GAP 1. Appendix A. Country Information PARALLELISM AND THE LEGITIMACY GAP 1 Appendix A Country Information PARALLELISM AND THE LEGITIMACY GAP 2 Table A.1 Sample size by country 2006 2008 2010 Austria 2405 2255 0 Belgium 1798 1760 1704 Bulgaria

More information

Prevention of Oral Cancer Special Interest Working Group

Prevention of Oral Cancer Special Interest Working Group Prevention of Oral Cancer Special Interest Working Group Dr Colwyn Jones, Consultant in Dental Public Health, NHS Health Scotland, 1 South Gyle Crescent, Edinburgh EH12 9EB, Scotland. colwyn.jones@nhs.net

More information

The Urgency of the Situation: The Cost of Childhood Obesity for Society

The Urgency of the Situation: The Cost of Childhood Obesity for Society The Urgency of the Situation: The Cost of Childhood Obesity for Society Lisa M. Powell, PhD Distinguished Professor and Director Health Policy and Administration School of Public Health University of Illinois

More information

Monthly measles and rubella monitoring report

Monthly measles and rubella monitoring report SURVEILLANCE REPORT Monthly measles and rubella monitoring report December 2018 Period covered: 1 November 2017 to 31 October 2018 Introduction This monitoring report is based on measles and rubella data

More information

THE NEW ZEALAND MEDICAL JOURNAL

THE NEW ZEALAND MEDICAL JOURNAL THE NEW ZEALAND MEDICAL JOURNAL Journal of the New Zealand Medical Association What proportion of cancer is due to obesity? Tony Blakely, Diana Sarfati, Caroline Shaw The evidence linking overweight and

More information

Trichinellosis SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods

Trichinellosis SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods Annual Epidemiological Report for 2015 Trichinellosis Key facts In 2015, a total of 156 confirmed cases of trichinellosis was reported from 29 EU/EEA countries. The overall notification rate was 0.03 cases

More information

HPV, Cancer and the Vaccination Programme

HPV, Cancer and the Vaccination Programme HPV, Cancer and the Vaccination Programme Dr Brenda Corcoran Consultant in Public Health Medicine HSE National Immunisation Office What is HPV? Human papillomavirus Over 200 types identified Spread by

More information

Louisville '19 Attachment #69

Louisville '19 Attachment #69 Telephone Meeting Approved and why I propose Using zoom to fulfill both Phone and Virtual video meeting Formats. The first established phone meeting Sanctioned by Gamblers Anonymous (listed on Trustee

More information

Q1 What age are you?

Q1 What age are you? Q1 What age are you? Answered: 504 Skipped: 0 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 4.56% 23 3.77% 19 4.56% 23 6.15% 31 3.97% 20 6.55% 33 5.95% 30 6.75% 34 6.35% 32 4.37% 22 6.75% 34 5.56%

More information

The Risk of Alcohol in Europe. Bridging the Gap June 2004

The Risk of Alcohol in Europe. Bridging the Gap June 2004 The Risk of Alcohol in Europe Bridging the Gap 16-19 June 2004 1. What is the relationship between alcohol and the risk of heart disease? 2. What is the relationship between alcohol and the risk of other

More information

EFSA s activities on data collection (Art. 33) and proposal for a new initiative (EUMENU) H. Deluyker Director

EFSA s activities on data collection (Art. 33) and proposal for a new initiative (EUMENU) H. Deluyker Director EFSA s activities on data collection (Art. 33) and proposal for a new initiative (EUMENU) H. Deluyker Director Scientific Cooperation and Assistance 43 rd Management Board Meeting Stockholm, 17 December

More information

EHFG 2016 Sustainable and equitable cancer care: tomorrow s reality or science-fiction?

EHFG 2016 Sustainable and equitable cancer care: tomorrow s reality or science-fiction? 1 Approval number EHFG 2016 Sustainable and equitable cancer care: tomorrow s reality or science-fiction? 28 th September 2016 The Oncologist s perspective What can and should be changed in order to optimise

More information

World Connections Committee (WCC) Report

World Connections Committee (WCC) Report World Connections Committee (WCC) Report 06 Co-Dependents Anonymous Service Conference Countries Where CoDA Exists This report reflects the World Connections Committee (WCC) support of the growth and development

More information

PRESS RELEASE ISSUED BY THE STATE UNIVERSITY OF NEW YORK AT ALBANY

PRESS RELEASE ISSUED BY THE STATE UNIVERSITY OF NEW YORK AT ALBANY PRESS RELEASE ISSUED BY THE STATE UNIVERSITY OF NEW YORK AT ALBANY EMBARGOED FOR RELEASE AT 6:00A.M. EST, FEBRUARY 20, 2001. NOTE TO EDITORS These results will be presented today (Tuesday, February 20,

More information

EuropaColon Uniting citizens in the fight against colorectal cancer. Zorana Maravic Director of Group Development May, 2013

EuropaColon Uniting citizens in the fight against colorectal cancer. Zorana Maravic Director of Group Development May, 2013 EuropaColon Uniting citizens in the fight against colorectal cancer Zorana Maravic Director of Group Development May, 2013 Colorectal cancer in Europe today >450,000 new diagnoses every year 2nd most common

More information

Where do EU Contries set the limit for low risk drinking.

Where do EU Contries set the limit for low risk drinking. Where do EU Contries set the limit for low risk drinking. Results from the EU RARHA survey E. Scafato,L. Galluzzo, S. Ghirini, C. Gandin Istituto Superiore di Sanità, Italy WP5: Outline of the work (tasks)

More information

Correction to: The education gradient in cancer screening participation: a consistent phenomenon across Europe?

Correction to: The education gradient in cancer screening participation: a consistent phenomenon across Europe? International Journal of Public Health https://doi.org/10.1007/s00038-018-1141-3 (0456789().,-volV)(0456789().,-volV) CORRECTION Correction to: The education gradient in cancer screening participation:

More information

Underage drinking in Europe

Underage drinking in Europe Underage drinking in Europe There are two major studies on underage drinking which are published every 4 years: HBSC (Health Behaviour in School-aged Children) and ESPAD (The European School survey Project

More information

WESTERN EUROPE PREVALENCE AND INCIDENCE OF PERIPHERAL ARTERY DISEASE AND CRITICAL LIMB ISCHEMIA 2017

WESTERN EUROPE PREVALENCE AND INCIDENCE OF PERIPHERAL ARTERY DISEASE AND CRITICAL LIMB ISCHEMIA 2017 WESTERN EUROPE PREVALENCE AND INCIDENCE OF PERIPHERAL ARTERY DISEASE AND CRITICAL LIMB ISCHEMIA 2017 Mary L. Yost 404-520-6652 , LLC 23 Ridge Rd. Beaufort, SC 20097 Copyright Pending 2017 All rights reserved,

More information

ALCOHOL CONSUMPTION IN EUROPE; TRADITIONS, GENERATIONS, CULTURE AND POLICY

ALCOHOL CONSUMPTION IN EUROPE; TRADITIONS, GENERATIONS, CULTURE AND POLICY ALCOHOL CONSUMPTION IN EUROPE; TRADITIONS, GENERATIONS, CULTURE AND POLICY JACEK MOSKALEWICZ INSTITUTE OF PSCHIATRY AND NEUROLOGY WARSAW, POLAND THIRD EUROPEAN CONFERENCE ON ALCOHOL AND LAW ENFORCEMENT,

More information

Dr Chris Jackson. Consultant Medical Oncologist Southern Blood and Cancer Service (SDHB) University of Otago

Dr Chris Jackson. Consultant Medical Oncologist Southern Blood and Cancer Service (SDHB) University of Otago Dr Chris Jackson Consultant Medical Oncologist Southern Blood and Cancer Service (SDHB) University of Otago 14:50-15:15 Priorities for Cancer Care in NZ - The Cancer Society's View Priorities for Cancer

More information

Chapter 6: Combined Cardiovascular Risk Factors

Chapter 6: Combined Cardiovascular Risk Factors Chapter 6: Combined Cardiovascular Risk Factors Key points Cardiovascular diseases such as coronary heart disease and stroke cause 44% of all deaths in New Zealand. The 1996/97 Health Survey provides information

More information

European Association of Dental Public Health Prevention of Oral Cancer

European Association of Dental Public Health Prevention of Oral Cancer European Association of Dental Public Health Prevention of Oral Cancer Special Interest Working Group Thursday 14th November 2013 PD Dr. Katrin Hertrampf, MPH Dr. Colwyn Jones, Associate Editor Malta 2013

More information

DECLARATION OF CONFLICT OF INTEREST. None

DECLARATION OF CONFLICT OF INTEREST. None DECLARATION OF CONFLICT OF INTEREST None Dietary changes and its influence on cardiovascular diseases in Asian and European countries Problems of Eastern European countries for cardiovascular disease prevention

More information

Biology Report. Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis?

Biology Report. Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis? Biology Report Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis? Introduction Tuberculosis is a serious disease caused by the bacterium Mycobacterium

More information

Who is a migrant? 12/10/2018. HIV and migrants. Heterogeneous groups of persons with different migration drivers

Who is a migrant? 12/10/2018. HIV and migrants. Heterogeneous groups of persons with different migration drivers HIV and migrants Julia del Amo has received research grants awarded to her institution from Companies BMS, Gilead, ViiV and epidemiology teaching fees from ViiV, Gilead and MSD Dr Julia del Amo National

More information

Rheumatoid Arthritis Disease Burden and Access to Treatment

Rheumatoid Arthritis Disease Burden and Access to Treatment Berlin, April 2012 Rheumatoid Arthritis Disease Burden and Access to Treatment Gisela Kobelt, PhD Visiting Professor, Lund University (Sweden) President, European Health Economics (France) Disclaimers

More information

OECD Family database OECD - Social Policy Division - Directorate of Employment, Labour and Social Affairs

OECD Family database  OECD - Social Policy Division - Directorate of Employment, Labour and Social Affairs SF.5: Childlessness Definitions and methodology The postponement of parenthood over the last decades, which can be gleaned from the declining percentage of childless women at different points over the

More information

European Experience and Perspective on Assessing Value for Oncology Products. Michael Drummond Centre for Health Economics, University of York

European Experience and Perspective on Assessing Value for Oncology Products. Michael Drummond Centre for Health Economics, University of York European Experience and Perspective on Assessing Value for Oncology Products Michael Drummond Centre for Health Economics, University of York Outline of Presentation The European landscape on access to

More information